• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TriSalus Life Sciences, Inc. - Common Stock (NQ:TLSI)

5.800 -0.340 (-5.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,305
Open 6.150
Bid (Size) 5.790 (1,900)
Ask (Size) 5.810 (1,100)
Prev. Close 6.140
Today's Range 5.750 - 6.300
52wk Range 3.420 - 7.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
December 04, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™
November 18, 2025
From TriSalus Life Sciences
Via Business Wire

Performance

YTD
-4.9%
-4.9%
1 Month
-20.0%
-20.0%
3 Month
+34.3%
+34.3%
6 Month
+18.6%
+18.6%
1 Year
+12.4%
+12.4%

More News

Read More
News headline image
TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q3 2025 Results with Strong Revenue Growth but Significant EPS Miss ↗
November 13, 2025
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
TriSalus (TLSI) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics Earnings
News headline image
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
November 13, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
November 11, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
November 10, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
October 30, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
August 28, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Strong Q2 2025 Revenue Growth and Narrowed Losses ↗
August 12, 2025
Via Chartmill
News headline image
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
August 12, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
Via Benzinga
News headline image
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
August 11, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 30, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
July 29, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
July 24, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
June 23, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
June 04, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
May 30, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
May 15, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
May 12, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
Earnings Scheduled For May 15, 2025 ↗
May 15, 2025
Via Benzinga
News headline image
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
April 30, 2025
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic ↗
March 27, 2025
Via Stocktwits

Frequently Asked Questions

Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
The current price of TriSalus Life Sciences, Inc. - Common Stock is 5.800
When was TriSalus Life Sciences, Inc. - Common Stock last traded?
The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 01/09/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap